Cdw Corporation · NASDAQ:CDW

Cdw — FY2015 Earnings Presentation

25 slides from Cdw's earnings presentation, Feb 9, 2016

  1. Slide 1: CDW Corporation Webcast Conference Call

    CDW Corporation Webcast Conference Call February 9, 2016 CDW.com | 800.800.4239

  2. Slide 2: Today's Agenda

    Today's Agenda ▪ Full year 2015 and 4th Quarter Results ▪ Key Performance Drivers and Strategic Progress ▪ Financial Results ▪ Outlook ▪ Questions & Answers 2

  3. Slide 3: Disclaimers

    Disclaimers This presentation contains forward-looking statements, which are any predications, projections, or other statements about future events. These statements are based on current expectations and assumptions that are subject to risks and uncertainties. Actual results could materially differ

  4. Slide 4: Demonstrates Strength of Business Model

    Demonstrates Strength of Business Model Highlights combined power of: ▪ Balanced portfolio of channels ▪ Broad product and solution suite ▪ Variable cost structure 4

  5. Slide 5: Record Full Year and 4th Quarter Performance

    Record Full Year and 4th Quarter Performance Full Year: ▪ Net sales up 7.6% to $13.0 billion; Organic net sales on a constant currency basis up 5.3% ▪ Adjusted EBITDA up 12.3% to $1.0 billion ▪ Non-GAAP net income per diluted share up 23.6% to $2.93 4th Quarter: ▪ Net sales up 12.1% to $3.4 billion;

  6. Slide 6: Balanced Portfolio Drove Topline

    Balanced Portfolio Drove Topline (Unaudited) ($ in millions) Three Months Ended December 31, Year Ended December 31, % Corporate: 2015 2014 Change(1) 2015 2014 % Change(2) Medium / Large $ 1,493.4 $ 1,440.3 3.7% $ 5,758.2 $ 5,485.4 5.0% Small Business 263.2 250.7 5.0 1,058.2 990.1 6.9 Total Corporat

  7. Slide 7: Our Three-Part Growth Strategy

    Our Three-Part Growth Strategy Gain "share of wallet" from existing customers and acquire new customers Enhance ability to deliver high-growth, integrated solutions Expand services capabilities 7

  8. Slide 8: Fourth Quarter Financial Results

    Fourth Quarter Financial Results (Unaudited) ($ in millions, except per share amounts) Three Months Ended December 31, 2015 2014 % Change Net sales $ 3,418.4 $ 3,050.1 12.1% Avg Daily Net Sales $ 54.3 $ 48.4 12.1% Gross profit $ 557.6 $ 491.9 13.4% % of Net Sales 16.3% 16.1% SG&A/advertising $ 377.7

  9. Slide 9: Fourth Quarter Adjusted SG&A and Adjusted EBITDA

    Fourth Quarter Adjusted SG&A and Adjusted EBITDA (Unaudited) ($ in millions) Three Months Ended December 31, 2015 2014 % Change Reported SG&A, including advertising $ 377.7 $ 327.6 15.3% Adjustments: Non-cash equity-based compensation (11.2) (4.9) Acquisition and integration expenses (1.5) — Other e

  10. Slide 10: Interest, Taxes and Non-GAAP Net Income

    Interest, Taxes and Non-GAAP Net Income (Unaudited) ($ in millions, except per share amounts) Three Months Ended December 31, 2015 2014 % Change Interest expense, net $ (38.4) $ (48.6) (21.0)% Other income, net $ 0.2 $ 1.3 (84.4)% Income tax expense $ (52.4) $ (28.3) 84.8% Net income $ 89.3 $ 51.8 7

  11. Slide 11: Fourth Quarter Non-GAAP Net Income

    Fourth Quarter Non-GAAP Net Income (Unaudited) ($ in millions) Three Months Ended December 31, 2015 2014 Net income $ 89.3 $ 51.8 Amortization of intangibles (1) 47.8 40.4 Non-cash equity-based compensation 11.2 4.9 Net loss on extinguishments of long-term debt — 36.9 Acquisition and integration exp

  12. Slide 12: Full Year Financial Results

    Full Year Financial Results (Unaudited) ($ in millions, except per share amounts) Year Ended December 31, 2015 2014 % Change Net sales $ 12,988.7 $ 12,074.5 7.6% Avg Daily Net Sales $ 51.1 $ 47.5 7.6% Gross profit $ 2,115.8 $ 1,921.3 10.1% % of Net Sales 16.3% 15.9% SG&A/advertising $ 1,373.8 $ 1,24

  13. Slide 13: Debt and Revolver Availability

    Debt and Revolver Availability (Unaudited) ($ in millions) December 31, September 30, December 31, 2015 2015 2014 Cash and cash equivalents $ 37.6 $ 97.5 $ 344.5 Total debt(1) $ 3,259.7 $ 3,267.8 $ 3,166.0 Senior secured debt $ 1,586.6 $ 1,595.8 $ 1,513.5 Net debt (total debt net of cash and cash eq

  14. Slide 14: Cash Conversion Cycle

    Cash Conversion Cycle (Unaudited) December 31, September 30, December 31, 2015 2015 2014 Days of sales outstanding (DSO) * 48 45 42 Days of supply in inventory (DIO) * 13 13 13 Days purchases outstanding (DPO) * (40) (40) (34) Cash Conversion Cycle * 21 18 21 * Based on a rolling three-month average

  15. Slide 15: Four Capital Allocation Priorities

    Four Capital Allocation Priorities Priorities Objectives Actions Target 30% payout of FCF Increase Dividends Annually 59% increase to $0.43/share in 5 years ~2.5 to 3.0 times Net Maintain Net Leverage Ratio (1) Currently at 3.0x (2) Leverage Ratio Supplement Organic Tuck-in, accretive deals Kelway a

  16. Slide 16: Capital Allocation Priorities Support Annual Medium Term Targets

    Capital Allocation Priorities Support Annual Medium Term Targets 2016-2018 Net Sales U.S. IT growth Growth +200-300bps* Adjusted Mid-7% Margin EBITDA Leverage Maintain net debt/adj. EBITDA ratio at ~2.5-3.0x Non-GAAP Low double-digits EPS Growth *Exceed in 2016 due to 7 months incremental Kelway and

  17. Slide 17: Thoughts on Modeling 2016

    Thoughts on Modeling 2016 For P&L currently look for: Revenue: • FY16 organic, constant currency growth within annual medium term target of 200 to 300 basis points above US IT market growth − Given current market volatility and macro uncertainty, closer to 2% earlier in the year • Dell to add up to

  18. Slide 18: Thoughts on Modeling 2016

    Thoughts on Modeling 2016 For P&L currently look for: NGNI and EPS: • FY16 book interest to be in the range of $155MM − Q1 slightly lower than 2015 due to quarter-end refinancing in 2015 • Effective tax rate to be between 37-38% • Share repurchases to offset dilution and contribute to achievement of

  19. Slide 19: Questions and Answers

    al Questions and Answers DU PEOPLE WHO GET IT 4 |

  20. Slide 20: Adjusted EBITDA to Net Income Reconciliation

    Adjusted EBITDA to Net Income Reconciliation (Unaudited) ($ in millions) Three Months Ended December 31, Year Ended December 31, % of Net % of Net % of Net % of Net 2015 sales 2014 sales 2015 sales 2014 sales Net income $ 89.3 $ 51.8 $ 403.1 $ 244.9 Depreciation and amortization(1) 62.4 52.0 227.4 2

  21. Slide 21: Full Year Adjusted SG&A

    Full Year Adjusted SG&A (Unaudited) ($ in millions) Year Ended December 31, 2015 2014 % Change Reported SG&A, including advertising: $ 1,373.8 $ 1,248.3 10.1% Adjustments: Non-cash equity-based compensation (31.2) (16.4) Acquisition and integration expenses (10.2) — Other expenses (1) (6.4) (9.7) De

  22. Slide 22: Full Year Non-GAAP Net Income

    Full Year Non-GAAP Net Income (Unaudited) ($ in millions) Year Ended December 31, 2015 2014 Net income $ 403.1 $ 244.9 Amortization of intangibles (1) 173.9 161.2 Non-cash equity-based compensation 31.2 16.4 Non-cash equity-based compensation from equity investment(2) 20.0 — Net loss on extinguishme

  23. Slide 23: Fourth Quarter Free Cash Flow

    Fourth Quarter Free Cash Flow (Unaudited) ($ in millions) Three Months Ended December 31, 2015 2014 % Change Net cash provided by operating activities $ (17.4) $ 84.5 Capital expenditures (46.3) (20.6) Net change in accounts payable - inventory financing 73.3 32.4 Free Cash Flow $ 9.6 $ 96.3 (90.0)%

  24. Slide 24: Full Year Free Cash Flow

    Full Year Free Cash Flow (Unaudited) ($ in millions) Year Ended December 31, 2015 2014 % Change Net cash provided by operating activities $ 277.5 $ 435.0 Capital expenditures (90.1) (55.0) Net change in accounts payable - inventory financing 95.9 75.5 Free Cash Flow $ 283.3 $ 455.5 (37.8)% 24

  25. Slide 25: Organic Net Sales Growth on a Constant Currency Basis

    Organic Net Sales Growth and Organic Net Sales Growth on a Constant Currency Basis (Unaudited) ($ in millions) Three Months Ended December 31, Year Ended December 31, % % 2015 2014 Change 2015 2014 Change Net sales, as reported $ 3,418.4 $ 3,050.1 12.1% $ 12,988.7 $ 12,074.5 7.6% Impact of acquisiti

CDW — FY2015 Earnings Presentation on 6ix